Jubilant Pharmova Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

784.70

810.12

87.75

2,709.50

3,139.90

Operating profit

16.50

3.22

-6.78

427.06

370.91

Interest

29.90

18.52

30.59

101.80

136.20

Gross profit

90.00

122.59

88.50

373.14

407.94

EPS (Rs)

1.99

3.13

4.93

13.46

20.16

Other income

103.40

137.89

125.87

47.88

173.23

Stock adjustment

39.00

3.45

-

55.21

-108.32

Raw material

310.00

396.30

-

1,328.92

1,683.29

Power and fuel

-

-

-

280.40

369.20

Employee expenses

190.00

167.27

49.21

220.67

264.90

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

229.20

239.88

45.32

397.24

559.92

Provisions made

-

-

-

-

-

Depreciation

48.30

43.25

6.25

99.97

107.40

Taxation

10.10

29.46

3.75

58.69

-22.30

Net profit / loss

31.60

49.88

78.50

214.48

321.14

Extra ordinary item

-

-

-

-

-1.70

Prior year adjustments

-

-

-

-

-

Equity capital

15.90

15.93

15.93

15.93

15.93

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

2.10

0.40

-7.73

15.76

11.81

GPM (%)

10.13

12.93

41.43

13.53

12.31

NPM (%)

3.56

5.26

36.75

7.78

9.69